About Amira Pharmaceuticals
Amira Pharmaceuticals is a company based in San Diego (United States) founded in 2005 was acquired by Bristol-Myers Squibb in July 2011.. Amira Pharmaceuticals has raised $39 million across 2 funding rounds from investors including Bristol-Myers Squibb, Versant Ventures and Prospect Venture Partners. Amira Pharmaceuticals operates in a competitive market with competitors including Nimbus Therapeutics, Escient Pharmaceuticals, Aclaris Therapeutics, Alpine Immune Sciences and Septerna, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$39 M (USD)
in 2 rounds
-
Latest Funding Round
$25 M (USD), Series B
Mar 23, 2007
-
Investors
Bristol-Myers Squibb
& 4 more
-
Employee Count
Employee Count
-
Acquired by
Bristol-Myers Squibb
(Jul 21, 2011)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Amira Pharmaceuticals
Amira Pharmaceuticals has successfully raised a total of $39M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $25 million completed in March 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $25.0M
-
First Round
First Round
(11 Jan 2006)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2007 | Amount | Series B - Amira Pharmaceuticals | Valuation | Avalon Ventures | |
| Jan, 2006 | Amount | Series A - Amira Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Amira Pharmaceuticals
Amira Pharmaceuticals has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Bristol-Myers Squibb, Versant Ventures and Prospect Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Founded Year | Domain | Location | |
|
Investments are made in US life sciences and healthtech firms.
|
Founded Year | Domain | Location | |
|
Seed and early-stage venture capital is provided to US companies.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Amira Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Amira Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Amira Pharmaceuticals Comparisons
Competitors of Amira Pharmaceuticals
Amira Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nimbus Therapeutics, Escient Pharmaceuticals, Aclaris Therapeutics, Alpine Immune Sciences and Septerna, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Novel dermatologic therapies are developed for skin conditions.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies to treat cancer and autoimmune disorders
|
|
| domain | founded_year | HQ Location |
GPCR drug discovery platform is developed for multiple diseases.
|
|
| domain | founded_year | HQ Location |
CRAC channel inhibitors are developed for inflammatory diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Amira Pharmaceuticals
Frequently Asked Questions about Amira Pharmaceuticals
When was Amira Pharmaceuticals founded?
Amira Pharmaceuticals was founded in 2005 and raised its 1st funding round 1 year after it was founded.
Where is Amira Pharmaceuticals located?
Amira Pharmaceuticals is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Amira Pharmaceuticals?
Bob Baltera is the current CEO of Amira Pharmaceuticals.
Is Amira Pharmaceuticals a funded company?
Amira Pharmaceuticals is a funded company, having raised a total of $39M across 2 funding rounds to date. The company's 1st funding round was a Series A of $14M, raised on Jan 11, 2006.
What does Amira Pharmaceuticals do?
Amira Pharmaceuticals was founded in 2005 and is based in San Diego, United States. Focus is placed on the discovery and early development of pharmaceuticals targeting inflammatory and fibrotic conditions. Drugs are developed for bioactive lipid pathways and signaling processes involved in diseases such as asthma, chronic obstructive pulmonary disease, cardiovascular disorders, and fibrosis. Operations emphasize preclinical stages within the biotechnology sector.
Who are the top competitors of Amira Pharmaceuticals?
Amira Pharmaceuticals's top competitors include Escient Pharmaceuticals, Nimbus Therapeutics and Alpine Immune Sciences.
Who are Amira Pharmaceuticals's investors?
Amira Pharmaceuticals has 5 investors. Key investors include Bristol-Myers Squibb, Versant Ventures, Prospect Venture Partners, Avalon Ventures, and Novo Holdings.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.